Search
for

    Sort by

    Research 271–300 of 1000+

    1. Safety and tolerability of low dose oral minoxidil monotherapy in female pattern hair loss: A retrospective review with longitudinal ambulatory blood pressure monitoring JAAD International · 2023
    2. CARDIOVASCULAR SAFETY OF LOW-DOSE ORAL MINOXIDIL FOR ANDROGENETIC ALOPECIA IN PATIENTS WITH HYPERTENSION OR ARRHYTHMIAS LUMEN ET VIRTUS · 2026
    3. Low-dose oral minoxidil for pediatric and young-adult hair loss: a cross-sectional survey of satisfaction and perceived benefit Archives of Dermatological Research · 2026
    4. EFFICACY AND SAFETY OF ORAL MINOXIDIL 2.5 MG ONCE DAILY IN MEN WITH ANDROGENETIC ALOPECIA: PROSPECTIVE SINGLE-CENTRE STUDY International Journal of Scientific Research · 2026
    5. Low-Dose Oral Minoxidil Improves Hairline and Eyebrow Coverage in Frontal Fibrosing Alopecia: A Prospective Study Dermatology and Therapy · 2026
    6. Quality of life and patient-reported side effects of low-dose oral minoxidil in treating female pattern hair loss. PubMed · 2026
    7. Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study Journal of the American Academy of Dermatology · 2026
    8. Quality of life and patient-reported side effects of low-dose oral minoxidil in treating female pattern hair loss Figshare · 2026
    9. Quality of life and patient-reported side effects of low-dose oral minoxidil in treating female pattern hair loss Figshare · 2026
    10. Low-Dose Oral Minoxidil as Treatment for COVID-19–Related Telogen Effluvium: Results From a Retrospective Series of 69 Patients Actas Dermo-Sifiliográficas · 2025
    11. Treatment of Short Anagen Syndrome With Low‐Dose Oral Minoxidil Pediatric Dermatology · 2025
    12. EFFICACY AND SAFETY OF LOW-DOSE ORAL MINOXIDIL IN THE TREATMENT OF ANDROGENETIC ALOPECIA – A LITERATURE REVIEW International Journal of Innovative Technologies in Social Science · 2025
    13. 61131 Impact of Low-Dose Oral Minoxidil on Blood Pressure in Androgenetic Alopecia Patients Concomitantly Taking Antihypertensive Medications: A Multi-Center Cohort Study Journal of the American Academy of Dermatology · 2025
    14. Low-Dose Oral Minoxidil During Chemotherapy: A Review of the Mechanism and Current Evidence Skin Appendage Disorders · 2025
    15. O04 Pharmacological efficacy of low-dose oral minoxidil–finasteride combination for hair growth and stability in male androgenetic alopecia: a 12-month retrospective service evaluation British Journal of Dermatology · 2025
    16. Use of low-dose oral minoxidil for hair growth in transgender and gender non-binary adult patients: a retrospective cohort study Journal of the American Academy of Dermatology · 2025
    17. A Randomised Controlled Trial Comparing the Therapeutic Efficacy and Safety of Oral Cyclosporine and Oral Betamethasone Minipulse Therapy in the Treatment of Alopecia Areata Cureus · 2025
    18. The Requirement to Monitor Low-dose Oral Minoxidil in the Management of Hair Loss International Journal of Trichology · 2025
    19. Low-dose oral minoxidil for androgenetic alopecia is not associated with blood pressure changes in patients also taking other antihypertensive medications: A multi-center cohort study using TriNetX Journal of the American Academy of Dermatology · 2025
    20. ASSESSING THE EFFECTIVENESS AND SAFETY OF LOW-DOSE ORAL MINOXIDIL IN ANDROGENETIC ALOPECIA: A 24-WEEK CLINICAL STUDY International Journal of Scientific Research · 2025
    21. Spironolactone reduces the risk of low-dose oral minoxidil-induced edema in women with female pattern hair loss. Journal of the American Academy of Dermatology · 2025
    22. Low-dose oral minoxidil for androgenetic alopecia is not associated with significant changes in alcohol consumption: a retrospective study of 21,971 patients Skin Appendage Disorders · 2025
    23. Low‐dose oral minoxidil in alopecia: evaluating blood pressure changes in patients with abnormal blood pressure—a retrospective study International Journal of Dermatology · 2025
    24. Expert Consensus Offers Guidance for Treating Hair Loss With Low-Dose Oral Minoxidil JAMA · 2024
    25. Gender differences in adverse effects and dosing practices of low-dose oral minoxidil for androgenetic alopecia: a retrospective analysis of 310 patients Skin Appendage Disorders · 2024
    26. Comparative analysis of low-dose oral minoxidil with spironolactone versus finasteride or dutasteride in female androgenetic alopecia management Archives of Dermatological Research · 2024
    27. 51297 Low dose oral minoxidil in COVID-19-associated telogen effluvium. A retrospective analysis of 69 patients. Journal of the American Academy of Dermatology · 2024
    28. Assessing low-dose oral minoxidil efficacy in androgenetic alopecia: a comparative study of AGA and AGA unmasked by telogen effluvium Archives of Dermatological Research · 2024
    29. Side Effects’ Frequency Assessment of Low Dose Oral Minoxidil in Male Androgenetic Alopecia Patients Skin Appendage Disorders · 2024
    30. Low-dose oral minoxidil for treatment of androgenetic alopecia: gender differences in blood pressure and hypotension-related adverse effects Journal of the American Academy of Dermatology · 2024